Home Cart 0 Sign in  

[ CAS No. 1163123-39-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1163123-39-4
Chemical Structure| 1163123-39-4
Structure of 1163123-39-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1163123-39-4 ]

Related Doc. of [ 1163123-39-4 ]

Alternatived Products of [ 1163123-39-4 ]

Product Details of [ 1163123-39-4 ]

CAS No. :1163123-39-4 MDL No. :MFCD16250626
Formula : C7H3ClFNO Boiling Point : -
Linear Structure Formula :- InChI Key :CBASZTHGTVVIGC-UHFFFAOYSA-N
M.W : 171.56 Pubchem ID :18966876
Synonyms :

Calculated chemistry of [ 1163123-39-4 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 38.98
TPSA : 26.03 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.34 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.12
Log Po/w (XLOGP3) : 2.82
Log Po/w (WLOGP) : 3.04
Log Po/w (MLOGP) : 2.01
Log Po/w (SILICOS-IT) : 2.96
Consensus Log Po/w : 2.59

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.29
Solubility : 0.0889 mg/ml ; 0.000518 mol/l
Class : Soluble
Log S (Ali) : -3.02
Solubility : 0.162 mg/ml ; 0.000946 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.8
Solubility : 0.0269 mg/ml ; 0.000157 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.25

Safety of [ 1163123-39-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1163123-39-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1163123-39-4 ]

[ 1163123-39-4 ] Synthesis Path-Upstream   1~1

  • 1
  • [ 1163123-40-7 ]
  • [ 1163123-39-4 ]
YieldReaction ConditionsOperation in experiment
76.4% at 20℃; for 2.5 h; Step 2: 2-Chloro-4-fluoro-benzooxazole
To a solution of 560 mg (3.31 mmol) 4-fluoro-benzooxazole-2-thiol in 3.6 mL (49.65 mmol) thionyl chloride was added dropwise 60.3 .box.L N,N-dimethylformamide dry at room temperature.
The mixture was stirred at room temperature for 2.5 h.
The solvent was removed in vacuo.
The crude compound was purified with flash column chromatography on silica eluding with a gradient formed from n-heptane and ethyl acetate to provide 434 mg (76.4percent) of the title compound as a white solid. MS(m/e): 171 (M+H+).
Reference: [1] Patent: US2009/163485, 2009, A1, . Location in patent: Page/Page column 13
Same Skeleton Products
Historical Records